Evidence suggests that bifidobacteria may regulate IGF-1 levels by improving insulin sensitivity,49 likely through preserving gut microbiota homeostasis, generating SCFAs and modulating metabolic signalling,50–52 including the mammalian target of the rapamycin pathway, which is upregulated in various inflammatory skin disorders.53 Here, INS is linked to inflammatory skin disease.